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ABSTRACT The aim of this study was to evaluate 
the effects of chloroquine on phagolysosomal fusion 
(PLF) in cultured guinea pig alveolar macrophages 
(AMs). This technique may be of significance for 
antitubercular drugs, because.the survival of 
Mycobacterium tuberculosis is linked to evasion of 
PLF. Guinea pig AMs were obtained from 
anesthetized animals after exsanguination. The AMs 
were cultured at a density of 1 x 10 6 cell/mL in 24-
well plates after attachment to 13-mm coverslips. 
Culture conditions were at 37oC, with 95% air/5% CO2
in Roswell Park Memorial Institute (RPMI) 1640 
medium with 10% heat-inactivated fetal bovine 
serum. Rhodamine-dextran (70 kd) was incubated 
with the cells at 0.25 mg/mL for 24 hours to label the 
lysosomes. Chloroquine treatment where indicated 
was performed at 10-20 µ g/mL for 1 hour. 
Fluorescent BioParticles were then added, and PLF 
was monitored by formation of an orange-yellow 
fluorescence on fusion of green fluorescent 
BioParticles with rhodamine-labeled lysosomes. PLF 
endpoints were measured by scoring for the 
percentage of orange-yellow cells in the field of view. 
Image analysis to measure the intensity of the orange-
yellow color was performed by obtaining a, b values 
for 5 x 5 pixel areas using the PhotoAdobe program 
4.0.1.  
The results indicated that the rate of PLF was 
enhanced by chloroquine. Thus, chloroquine may be 
used to potentiate the effects of rifampicin. This may 
be confirmed by studies involving similar dual 
fluorophore labeling techniques of fluorescein-labeled 
formulation in macrophages infected with M. 
tuberculosis. Preliminary studies with the rhodamine-
labeled formulation confirmed cellular uptake and 
persistence for up to 7 days in culture. 
INTRODUCTION 
Worldwide, tuberculosis (TB) remains the single most 
important infectious disease in adults. Each year, 8 
million people develop new cases of TB and 3 million 
die (1,2). Pulmonary deposition of the causative 
organism Mycobacterium tuberculosis (MTB) leads to 
1 of 4 possible outcomes: 1) immediate clearance of 
the organism, leaving no trace of infection; 2) 
asymptomatic chronic infection; 3) active disease 
soon after infection; or 4) active disease many years 
after the primary infection. The fate of inhaled bacilli 
at the site of infection depends on the capacity of the 
organism to proliferate after the alveolar macrophages 
(AM) ingest them and the AM's capacity to arrest 
their growth (3,4). Hence, the interaction of the 
pathogen with the AM is a key factor in the outcome. 
The intracellular growth of MTB has been attributed 
to various suggested pathways. Evasion of 
phagolysosomal fusion (PLF) and thereby evasion of 
the lysosomal hydrolases is one of the putative 
mechanisms (5,6). Various mechanisms by which the 
bacillus is able to accomplish this objective have been 
suggested. Studies by Goren et al (7) demonstrated 
that purified sulfatides from MTB strain H37Rv 
displayed potent inhibition of phagolysosome 
formation. This inhibition was attributed to the 
accumulation of the sulfatides in secondary 
lysosomes, rendering them incompetent to fuse with 
phagosomes. Studies by another group (8) 
demonstrated inhibition by filtrates from tubercle 
bacilli cultures, attributed to the large amounts of 
ammonia present as PLF activity was.restored on 
replacement with normal culture media. 
Mycobacterium microti was found to inhibit PLF by 
inhibition of lysosomal movements, possibly by 
modifying microtubule controls (9). 
The evasion of PLF may also explain the added 
difficulty in obtaining proximity of drug to pathogen 
that stays intracellularly sequestered in a protective 
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environment. As reported earlier (10), modest doses 
of chloroquine were used to enhance PLF. Potentially, 
chloroquine may be used to modulate PLF to enhance 
the proximity between antitubercular drugs and the 
intracellular pathogen. The effect of chloroquine at the 
dose employed was studied by using a dual 
fluorophore PLF assay as reported by Duzgunes et al 
(11). The aim of the study was to adopt the above 
technique for cultured guinea pig alveolar 
macrophages (AMs) and examine the role of 
chloroquine on the PLF in guinea pig AM. 
Preliminary studies examined the intracellular fate of 
rhodamine-labeled rifampicin polylactic-co-glycolic 
acid (RR-PLGA) microspheres. 
MATERIALS AND METHODS 
Materials
Rifampicin was obtained from Sigma Chemicals, St 
Louis, MO; 75:25 poly-lactic-co- glycolic acid 
(PLGA), 80 000 MW, was obtained from 
Birmingham Polymers, Birmingham, AL; and 
glycerol and formaldehyde were obtained from Fisher 
Scientific, Pittsburgh, PA. Polyvinyl alcohol, 78 000 
MW, was obtained from Polysciences Inc, 
Warrington, PA; isopropyl alcohol and methylene 
chloride were.from Mallinckrodt, St  Louis, MO; and 
rhodamine 6G chloride, rhodamine-dextran 70 000 
MW, and fluorescein-labeled BioParticles were from 
Molecular Probes, Portland, OR. Hank’s Balanced 
Salt Solution, Ca 2+ - and Mg 2+ -free, RPMI 1640 
medium, fetal bovine serum, and penicillin-
streptomycin solution were obtained from Gibco 
BRL, Grand Island, NY, and chloroquine was from 
Fluka, Milwaukee, WI. 
Equipment
The following equipment was used in the study: 22-
gauge stainless steel 10-inch-long luer hub and 
deflecting tip needle (Aldrich Co., Milwaukee, WI), 
10 cc Micromat® syringes (Popper and Sons, New 
Hyde Park, NY), lab dispersator (Premier Mill Corp, 
Reading, PA), centrifuge (IEC-22M), Napco vacuum 
oven #5831 (Precision Scientific, Chicago, IL), 
sonicator (Fisher Scientific FS21H), 13-mm round 
glass coverslips (Ernest Fullam Inc, Latham, NY), 24-
well culture plates (Costar, Cambridge, MA), electron 
microscope (JEOL 6300 system electron microscope, 
Peabody, NY), fluorimeter (Perkin-Elmer 
luminescence spectrometer LS50B, Norwalk, CT), 
microscope (Nikon B-2A, Nikon Inc, Garden City, 
NY), Sigma Scan Software, and Adobe Photoshop 
4.0.1.
Methods




glycolic acid (RR-PLGA) microspheres were 
manufactured by the emulsification solvent 
evaporation technique using the solubility of 
rifampicin in organic solvents such as methylene 
chloride (12). The polymer and the drug-dye 
mixture were separately dissolved in methylene 
chloride in equal volumes. Sonication was used for 
20 seconds to aid dissolution of the polymer. 
Subsequently the polymer solution was added to the 
drug-dye solution. The continuous phase was a 70% 
vol/vol glycerol and a 0.05% wt/vol polyvinyl 
alcohol (PVA) aqueous solution. The PVA was 
added to the requisite amount of distilled water and 
warmed to 65ºC. The solution was mixed with 
glycerol to achieve the desired concentration. The 
microspheres were prepared by the addition of 4 mL 
of the polymer-drug-dye solution in methylene 
chloride to 100 mL of the continuous phase, chilled 
between 4ºC and 10ºC, and administered with a 
syringe attached to a 10-inch-long needle. The 
mixture was agitated with a dispersator at 5500 
rpm. After 15 minutes, the ice bath was replaced 
with a water bath warmed to 45ºC for 5 minutes to 
enhance the evaporation of organic solvent with 
continued dispersion at 5500 to 6000 rpm. The 
contents were then transferred to a 5% isopropyl 
alcohol solution and stirred vigorously for 30 
minutes with a magnetic stirrer (Corning PC 351, 
Corning, NY). The microsphere suspension was 
subjected to repeated centrifugation at 12 000 rpm 
to remove residual isopropyl alcohol. The 
centrifuge vials were then placed overnight in a 
vacuum oven under a vacuum of 27 in Hg without 
heating, and the  microspheres obtained were 
collected on drying. They were then placed over 
desiccant at –20ºC. 
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Terminal sterilization cannot be employed because 
PLGA has been known to deteriorate as a result of 
irradiation (13). Hence, the entire manufacture 
operation described above was carried out in a clean 
environment to prevent the appearance of 
contamination under culture conditions. Briefly, all 
glassware and stainless steel components were 
autoclaved before use. Equipment was swabbed 
with 70% ethanol, and the manufacture was 
performed under UV illumination (Blak-Ray long-
wave UV lamp, Upland, CA). Sterile  water was 
used for injection, and the drug-polymer solution 
was filter sterilized using a Millex-FG 0.22 ∝ m 
filter (Millipore, CA). No contact with the ice bath 
occurred during manufacture. The product was 
dried under a laminar flow hood. The product 
obtained by this modified technique did not exhibit 
altered characteristics compared with that prepared 
without clean technique.  
Microsphere characterization
The microspheres were dispersed in distilled water, 
applied to a stub, and dried overnight in a vacuum 
oven. Microspheres were sputter coated with gold-
palladium before examination using a scanning 
electron microscope. Photomicrographs of the 
particle images were obtained (Polaroid, 
Cambridge, MA). 
Particle size analysis 
The photomicrographs were used to perform 
particle size analysis (Sigma Scan software, Jandel,  
Sunnyvale, CA). The dimensions of 500 
microparticles were.measured, and the mass median 
diameter and the geometric standard deviation were 
calculated, assuming a log-normal distribution (14). 
Rhodamine-release profile
The rhodamine loading was determined by 
dissolving 10 mg RR-PLGA microspheres in 1 mL 
chloroform followed by precipitation of the polymer 
with 9 mL methanol as described by Denkbas et al 
(15). The  supernatant was analyzed for rhodamine 
by fluorimetric analysis employing excitation 
wavelength at 529 nm and emission wavelength of 
551 nm. The release of rhodamine was determined 
over 24 hours by analyzing the supernatant after 
suspending 15 mg of RR-PLGA microspheres in 5 
mL of phosphate buffer at 37 o C, with a pH of 7.4.  
Uptake and degradation studies with RR-PLGA 
microspheres 
Alveolar macrophages were harvested from Dunkin-
Hartley guinea pigs by bronchoalveolar lavage with 
Hank's Balanced Salt Solution (HBSS), Ca 2+ - and 
Mg 2+ -free buffer after anesthetization and 
exsanguination of the animal. The cells obtained were 
washed by alternate centrifugation and resuspension at 
500g. The viability and cell count were determined by 
employing a 1:1 mixture of cell suspension and trypan 
blue solution. The cells were then plated onto 13-mm 
glass coverslips at a density of 1 x 10 5 cells/mL in 24-
well plates. The cell culture medium was RPMI 1640 
with 10% vol/vol heat-inactivated fetal bovine serum, 
penicillin G-100 U/mL, and streptomycin-100 µ 
g/mL. After 2 hours the non-adherent cells were 
gently washed and, where indicated, chloroquine (10-
20 µ g/mL) was added to the wells for 1 hour and then 
replaced with fresh media. RR-PLGA microspheres 
were added to the wells at differing (3:1,10:1) 
sphere:cell ratios for.6 hours and then replaced with 
media. The excess spheres were washed away and the 
cells resuspended in RPMI medium. At discrete 
timepoints over 7 days, the coverslips were removed 
and the cells fixed by addition of 2% HCHO and 
visualized by fluorescence microscopy employing a 
rhodamine filter. 
Measurement of PLF and study of the effect of 
chloroquine
Uptake studies with fluorescein-labeled BioParticles
Similar studies with BioParticles were conducted to 
evaluate PLF in cultured guinea pig AMs as reported 
earlier (11). The lysosomes were labeled with 
rhodamine-dextran (0.25 mg/mL) for 24 hours. The 
excess dye was washed and the cells were then 
incubated at a sphere:cell ratio of 3:1 with fluorescein-
labeled BioParticles, thereby labeling the endosomes 
green. Phagolysosomal fusion events were measured 
by scoring individual cells over 10 randomly chosen 
fields of view. The cells were scored as fusion/non-
fusion events based on the appearance of an orange-
yellow color obtained by the merging of the green 
fluorescence with the red fluorescence of rhodamine. 
PLF intensity was studied by measuring the intensity 
of the orange-yellow color. The intensity was obtained 
by measuring arbitrary a, b values for 5 x 5 pixel areas 
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from cells with the Adobe Photoshop 4.0.1 software 
program at 60X magnification. As reference points 
and to validate the software, images were collected 
from control cells with no fluorophores, cells loaded 
with rhodamine-dextran only, and fluorescein-labeled 
BioParticles. These measurements were performed to 
determine whether the intensity of the color changed 
as a result of probable fusion of more lysosomal 
compartments with the endosome possibly leading to 
subtle differences in the hue obtained. 
RESULTS AND DISCUSSION 
Study of rhodamine-labeled formulation 
Microsphere manufacture and characteristics
The solvent evaporation technique produced smoothly 
rounded microspheres (Figure 1), indicating uniform 
evaporation and solvent extraction from the droplet. 
The median diameter was found to be 0.5 µm with a 
geometric standard deviation of 1.8 (Figure 2). 
Generally, these microspheres were smaller in 
diameter than rifampicin-loaded microspheres, 
probably because of the additive effect of the planar 
configurations of rhodamine and rifampicin molecules 
and their possible surface adsorption. The size profile 
determined demonstrated the microspheres to be in 
the size range for optimal phagocytosis by the alveolar 
macrophages. 
The formulation manufactured under a clean 
environment was found to be suitable as it did not 
contribute any confounding contamination when 
incubated with the guinea pig AMs. The limiting 
condition remained the limited lifetime of primary 
culture of up to 7 days. Rhodamine was the 
fluorophore of choice to examine the behavior of the 
formulation because rhodamine is uniformly intense 
over a broad pH range (pH 4-9). 
Rhodamine-release profile
The rhodamine loading was found to be 0.42% ± 
0.04% versus a theoretical loading of 1%. The release 
pattern reflected a slow rhodamine release of only 
2.5% over a day (Figure 3). This reflected release 
restricted by polymer degradation because of its high 
molecular weight of 80 000. The slow release of 
rhodamine indicated suitability of the use of 
rhodamine as a marker for long-term studies of the 
formulation under culture conditions. 
Figure 1. Log-probability plot of the size analysis of rhodamine-labeled 
rifampicin polylactic-co-glycolic acid microspheres (Median diameter 
0.473 µm [GSD 2.09]). 
Figure 2. Representative photomicrograph of rhodamine-labeled 
rifampicin polylactic-co-glycolic acid microspheres. 
Figure 3. Rhodamine release profile from rhodamine-labeled rifampicin 
polylactic-co-glycolic acid microspheres (n=5). 
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Uptake and degradation studies with RR-PLGA 
microspheres
The studies indicated a persistence of intact 
microspheres within cultured guinea pig AMs up to 7 
days in culture (Panel 1). This time frame was limited 
mainly due to detachment of cells from the coverslip 
surface owing to the typical characteristics of a 
primary culture. The persistence of intact 
microspheres within cells may be attributed to the 
composition of the polymer (75:25 PLGA) and its 
high molecular weight. Studies by Tabata and Ikada 
(16) demonstrated that the lifetime of PLGA 
microspheres within mouse peritoneal macrophages 
was found to be dependent on the monomer 
composition and polymeric weight. The authors 
reported persistence of polylactic acid microspheres 
(MW 13 000) up to 7 days in culture. Varying degrees 
of diffuse red fluorescence were observed in the 
cytoplasm, indicating degradation of the microsphere 
over time, a pattern witnessed by Tabata and Ikada in 
similar studies (16). 
Chloroquine has been reported to be a 
phagolysosomal fusion enhancer when employed at 
modest doses, while at higher doses it has been 
reported to be capable of shutting down intracellular 
trafficking due to lysosomal rupture (17). Chloroquine 
treatment (10 µ g/mL) did not sharply alter the time 
point for the appearance of a diffuse fluorescence, 
which may partly be a shortcoming of the technique, 
as it relied on the individual perception for subtle 
differences in the extent of diffuseness of the intensely 
bright rhodamine. However, chloroquine did exert a 
protective effect on the cells at a sphere:cell ratio of 
10:1 compared with the control group as fewer cells 
detached over time. This may be due to rapid turnover 
of excess polymeric by-products.  
Measurement of PLF and Study of the Effect of 
Chloroquine
Uptake with BioParticles
The further investigation of doses of chloroquine 
employed in our system on PLF was carried out using 
a dual fluorophore system. This system enhances the 
visualization of PLF events by the formation of an 
orange-yellow color on fusion of the green fluorescent 
endosomal compartment with the red fluorescent 
lysosomal compartment. 
Panel 1. Photomicrographs of alveololar macrophages containing 
rhodamine-labeled rifampicin polylactic-co-glycolic acid (RR-PLGA ) 
microspheres at a) 24 hours, b) 4 days, and c) 6 days. Cells stayed in 
culture for 7 days and began detaching. Patterns of punctate to diffuse 
fluorescence was observed over time, indicating the slow degradation of 
RR-PLGA microspheres. 
Panel 2. Photomicrographs of alveolar macrophages with BioParticles 
and rhodamine-dextran. a) cells depicting pinpoint red lysosomes b) few 
cells with freshly phagocytosed BioParticles c) cells displaying orange-
yellow fluorescence indicating phagolysosomal fusion 
Panel 2 depicts various stages in the phagolysosomal 
process, with the formation of orange-yellow 
fluorescence resulting from the fusion events that are 
occurring. The rate of fusion was measured by scoring 
fields of view for cells exhibiting orange-yellow 
fluorescence over time at 40X magnification. The 
phagocytic index was also compared to ensure that 
chloroquine did not alter the.phagocytic uptake on 
incubation with the cells. Figure 4 depicts the kinetics 
of PLF in the different groups. The PLF kinetics were 
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Figure 4. Kinetics of phagolysosomal fusion over time in control and
treatment groups (n=5). For each timepoint, cells over 10 fields of view at
40X were scored as fusion/non-fusion events depending on visualization of
the orange-yellow color formed on fusion between endosomes and
lysosomes. The percentage of.phagolysosomal fusion was then obtained by
dividing the number of cells by the total number of cells in the field of view. 
Figure 5. Scatter patterns for 5 x 5 pixel areas of a, b values of rhodamine-
dextra-treated cells alone (red fluorescence) or fluorescein-labeled
BioParticles exposed cells alone (green fluorescence). In the Lab scale
system, green to red values range from -120 to +120. The cluster of scatter
points on the left-hand side of the graph corresponds to a, b values for 5 x 5
pixel areas (at 60X) treated with only fluorescein-labeled BioParticles, while
the cluster of points on the right-hand side corresponds to cells treated with
only rhodamine-labeled dextran (70 kd).  
Figure 6. Scatter patterns for 5 x 5 pixel areas of a,b values of rhodamine-
dextra-treated and fluorescein-labeled BioParticles exposed cells. The profile
of the a, b values for the 5 x 5 pixel areas of cells visually displaying an
orange-yellow color falls in between the values for the corresponding a, b
values for 5 x 5 pixel areas for fluorescein-labeled BioParticles only-and
rhodamine-dextran only-treated cells displayed in Figure 5. 
enhanced in the treatment groups, which were 
enhanced compared with the control group. This trend 
was, however, equalized over a period of 4 hours. 
D’Arcy Hart and Young reported acceleration of PLF 
at a 1 hour time point after treatment with 20 µg/ml 
for 45 minutes (10). The mechanism of action of 
chloroquine is in part a result of its basic nature and its 
sequestration within lysosomes where it exerts its 
effect (11). Such subtle manipulation may be 
employed to improve the vicinity of surface-
associated drug in microsphere formulations to 
intracellular pathogens. 
An image analysis of cells at 60X magnification with 
scoring of 5 x 5 pixel areas for the intensity of color 
showed a different stagger pattern of the a, b values 
for cells treated with rhodamine-dextran alone or 
those incubated with fluorescein-labeled BioParticles 
alone (Figure 5). The Lab color analysis system 
distinguishes between colors and hues based on an 
arbitrary numeric scale. TheLab color consists of a 
luminance, or brightness component, and 2 chromatic 
component - the a component, which ranges from 
green to red, and the bcomponent, which ranges from 
blue to yellow. The Lab mode has been employed to 
edit the luminance and color values in the images 
independently. 
The a component (green-red) axis and the b-
components (blue to yellow) axis can range in scale 
from -120 to +120 (18). The Lab scale is clearly 
suitable to measure a transition from green to red as 
the a component measures the green to red transition. 
The stagger pattern of the cells depicting an orange-
yellow color.yielded a pattern with points that fell 
between the red only or green only zones (Figure 6). 
Similar data presentation and interpretation have been 
reported by Bruce et al (19). The authors employed a 
Hoechst 33342 staining of lung fibroblasts and 
compared the scatter values between the red and blue 
fluorescence obtained by flow cytometry to study 
apoptosis in postnatal lung fibroblasts. 
The process did not reveal any differences in the 
intensity of color, especially visually to the 
experimenter. However, a set of a, b values 
intermediate to that between the green and red values 
were obtained as evidenced by Figures 5 and 6. This 
may result from the cells reaching a similar endpoint 
in the fusion process (e.g., a similar number of 
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lysosomes may fuse with an endosome leading to the 
formation of the same "hue"). It is equally likely that 
the modest dose of chloroquine served only to affect 
the kinetics and not the extent of fusion. The studies 
reflected that it is possible to monitor the intracellular 
behavior of formulations that treat intracellular 
pathogens or exert an action intracellularly. 
Chloroquine was found to modestly enhance the rate 
of PLF over 4 hours, and such strategies might safely 
manipulate naturally occurring physiological 
mechanisms that aid health and combat disease. 
Similar studies in survival of the intracellular TB in 
infected macrophages on treatment with rifampicin 
microspheres and chloroquine in tandem remains to 
be assessed to further understand the subtle intricacies 
of physiological functioning of the AM resulting in 
health or disease. 
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